Quotient Therapeutics
Discover how Quotient is pioneering a new field of genetics with somatic genomics to unveil a universe of genetic information and develop new therapies.
- Total raised
- $50M
- Latest round
- Seed
- Employees
- 76
About Quotient Therapeutics
We transform somatic genomics insights into potentially breakthrough medicines. Learn more at Quotient-Tx.com
Funding & revenue at Quotient Therapeutics
How well capitalized the business is — useful context before you scope a fractional engagement or negotiate a rate.
Total capital raised
$50M
1 known investor
Latest round
Seed · $50M
Nov 2023
Investors
Growth signals
How fast Quotient Therapeutics is adding people, roles, and audience.
Employees
76
Reported band 51-200
LinkedIn followers
8.2K
+22.5% year over year
Headcount change
- MoM
- 0%
- QoQ
- -2.6%
- 6mo
- +4.1%
- YoY
- +2.7%
- 2yr
- +61.7%
0 people
-2 people
+3 people
+2 people
+29 people
Team composition
Where Quotient Therapeutics concentrates its people — a read on which function a fractional leader would plug into.
By function
- Research4255%
- Business Development1317%
- Engineering79%
- Operations34%
By region
- United Kingdom47
- England, United Kingdom43
- United States28
- Greater Boston27
- Massachusetts, United States27
- Cambridge19
Inside Quotient Therapeutics
What the business focuses on, where it operates, and how employees rate it.
Categories
Markets
Offices
- Chesterford Research Park, Little Chesterford, England, GB
Jobs
0No open roles right now — view past roles below
Funding, revenue, headcount, and hiring figures are third-party estimates from public sources and are not confirmed by the company. Last refreshed August 16, 2026.
About this page
This company page is automatically generated based on publicly available job postings. Company information is sourced from publicly available data and may not be complete. If you represent Quotient Therapeutics, you can claim this page to manage and enhance it.